These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 11239718)
1. Activation of CB1 cannabinoid receptors in rat hippocampal slices inhibits potassium-evoked cholecystokinin release, a possible mechanism contributing to the spatial memory defects produced by cannabinoids. Beinfeld MC; Connolly K Neurosci Lett; 2001 Mar; 301(1):69-71. PubMed ID: 11239718 [TBL] [Abstract][Full Text] [Related]
2. Mechanisms of cannabinoid inhibition of GABA(A) synaptic transmission in the hippocampus. Hoffman AF; Lupica CR J Neurosci; 2000 Apr; 20(7):2470-9. PubMed ID: 10729327 [TBL] [Abstract][Full Text] [Related]
3. Cannabinoid CB1 receptor-mediated inhibition of acetylcholine release in the brain of NMRI, CD-1 and C57BL/6J mice. Kathmann M; Weber B; Schlicker E Naunyn Schmiedebergs Arch Pharmacol; 2001 Jan; 363(1):50-6. PubMed ID: 11191836 [TBL] [Abstract][Full Text] [Related]
4. Cannabinoid receptor-mediated inhibition of acetylcholine release from hippocampal and cortical synaptosomes. Gifford AN; Bruneus M; Gatley SJ; Volkow ND Br J Pharmacol; 2000 Oct; 131(3):645-50. PubMed ID: 11015319 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of serotonin release in the mouse brain via presynaptic cannabinoid CB1 receptors. Nakazi M; Bauer U; Nickel T; Kathmann M; Schlicker E Naunyn Schmiedebergs Arch Pharmacol; 2000 Jan; 361(1):19-24. PubMed ID: 10651142 [TBL] [Abstract][Full Text] [Related]
6. Cannabinoid CB1 receptor-mediated inhibition of NMDA- and kainate-stimulated noradrenaline and dopamine release in the brain. Kathmann M; Bauer U; Schlicker E; Göthert M Naunyn Schmiedebergs Arch Pharmacol; 1999 Jun; 359(6):466-70. PubMed ID: 10431757 [TBL] [Abstract][Full Text] [Related]
7. Cannabinoid receptor activation in CA1 pyramidal cells in adult rat hippocampus. Kirby MT; Hampson RE; Deadwyler SA Brain Res; 2000 Apr; 863(1-2):120-31. PubMed ID: 10773200 [TBL] [Abstract][Full Text] [Related]
8. Electrically evoked acetylcholine release from hippocampal slices is inhibited by the cannabinoid receptor agonist, WIN 55212-2, and is potentiated by the cannabinoid antagonist, SR 141716A. Gifford AN; Ashby CR J Pharmacol Exp Ther; 1996 Jun; 277(3):1431-6. PubMed ID: 8667207 [TBL] [Abstract][Full Text] [Related]
9. Effects of the endogeneous cannabinoid, anandamide, on neuronal activity in rat hippocampal slices. Ameri A; Wilhelm A; Simmet T Br J Pharmacol; 1999 Apr; 126(8):1831-9. PubMed ID: 10372827 [TBL] [Abstract][Full Text] [Related]
10. Large receptor reserve for cannabinoid actions in the central nervous system. Gifford AN; Bruneus M; Gatley SJ; Lan R; Makriyannis A; Volkow ND J Pharmacol Exp Ther; 1999 Feb; 288(2):478-83. PubMed ID: 9918548 [TBL] [Abstract][Full Text] [Related]